Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

Investors increased their allocations to pharmaceuticals (NYSEARCA:PJP), (NYSEARCA:XPH), (PPH), banks (KRE) and industrials ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

The IPO of Onyx Biotec Limited was fully subscribed for within hours of its Wednesday, November 13 launch. There was a high ...

With the respiratory illness season starting up in earnest, Vicks has reclaimed the top Rx and over-the-counter (OTC) pharma ...

Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has structured its capital to enable significant growth opportunities, with ...

Urogen's UGN-102 presents a $5B market opportunity for bladder cancer treatment, despite risks. Read more about URGN stock ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

Ascendis Pharma (ASND) is scheduled to announce Q3 earnings results on Thursday, November 14th, after market close. The ...

SPIMACO, a leading Saudi Arabia-based pharma company, announced the signing of sale and purchase agreements (SPAs) with the principal shareholders of Osmopharm, a Swiss-based innovation-driven ...